Orchard Hill Reports a 10% Stake in Supernus Pharmaceuticals

Orchard Hill, Supernus Pharmaceuticals: Earlier this year, Orchard Hill Capital Management purchased a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) which contained 3.5 million shares, a new filing with the SEC stated. Orchard Hill holds 10.2% of the company.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

Disclosure: none

Recommended Reading:

Mason Hawkins, Southeastern Asset Management Up Stake in Guinness Peat

4 Videos of Warren Buffett on Piers Morgan That Will Make Your Morning

Billionaire Ken Fisher’s 3 Top Stock Picks